Australia
# |
Name |
EBT Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
72.13%
|
June 30, 2024 | USD 157.25 | 0.24% |
|
Australia |
|
2 |
57.47%
|
June 30, 2024 | USD 7.32 | 6.16% |
|
Australia |
|
3 |
22.97%
|
June 30, 2024 | USD 173.13 | 0.11% |
|
Australia |
|
4 |
6.71%
|
June 30, 2024 | USD 21.11 | 1.40% |
|
Australia |
|
5 |
5.27%
|
June 30, 2024 | USD 2.14 | 0.82% |
|
Australia |
|
6 |
2.90%
|
June 30, 2024 | USD 20.43 | 1.47% |
|
Australia |
|
7 |
1.66%
|
June 30, 2024 | USD 1.33 | 6.17% |
|
Australia |
|
8 |
0.62%
|
Dec. 31, 2023 | USD 15.47 | 4.25% |
|
Australia |
|
9 |
0.26%
|
Jan. 31, 2024 | USD 1.81 | -0.44% |
|
Australia |
|
10 |
-15.44%
|
Dec. 31, 2023 | USD 1.27 | -1.68% |
|
Australia |
|
11 |
-20.07%
|
June 30, 2024 | USD 0.62 | -2.68% |
|
Australia |
|
12 |
-48.97%
|
June 30, 2024 | USD 2.80 | 2.04% |
|
Australia |
|
13 |
-141.49%
|
June 30, 2024 | USD 2.00 | 1.52% |
|
Australia |
|
14 |
-252.36%
|
June 30, 2024 | USD 0.74 | -1.40% |
|
Australia |
|
15 |
-365.26%
|
June 30, 2024 | USD 2.37 | 1.84% |
|
Australia |
|
16 |
-474.65%
|
June 30, 2024 | USD 3.31 | -4.06% |
|
Australia |
|
17 |
-1,111.87%
|
June 30, 2024 | USD 1.93 | -0.52% |
|
Australia |
|
18 |
-1,171.97%
|
June 30, 2024 | USD 1.53 | 1.32% |
|
Australia |
|
19 |
-1,493.51%
|
June 30, 2024 | USD 1.58 | -2.06% |
|
Australia |
|
20 |
-1,680.35%
|
Dec. 31, 2023 | USD 5.88 | 0.14% |
|
Australia |
|
21 |
-153,575.00%
|
June 30, 2024 | USD 1.77 | -1.67% |
|
Australia |
|
22 |
-184,215.67%
|
June 30, 2024 | USD 3.82 | 6.70% |
|
Australia |
The Pharmaceuticals company in Australia with the highest EBT Margin is Pro Medicus Limited (ASX: PME.AX) at 72.13%.
The Pharmaceuticals company in Australia with the lowest EBT Margin is Opthea Limited (NasdaqGS: OPT) at -184,215.67%.
The top 10 Pharmaceuticals companies in Australia by EBT Margin are Pro Medicus Limited, Clinuvel Pharmaceuticals Limited, CSL Limited, Ansell Limited, Australian Clinical Labs Limited, EBOS Group Limited, PolyNovo Limited, Telix Pharmaceuticals Limited, Sigma Healthcare Limited and Cyclopharm Limited.
The bottom 10 Pharmaceuticals companies in Australia by EBT Margin are Opthea Limited, Incannex Healthcare Limited, Anteris Technologies Ltd, Mesoblast Limited, Kazia Therapeutics Limited, Immutep Limited, Alterity Therapeutics Limited, Clarity Pharmaceuticals Ltd, PYC Therapeutics Limited and Immuron Limited.